The use of sensitive, including health, data and the digitalisation of processes have been at the heart of projects meant to fight the Covid-19 pandemic. In light of the increasing usage of such data these last months, one should pay attention to how privacy is protected. An international overview of the policies in place, or being developed by regulatory authorities in different jurisdictions, may contribute to a dialogue about ‘best practices’ in the context of the protection of such data while Covid-19 is still spreading.
The webinar is part of a series of webinars, organised by the IBA Healthcare and Life Sciences Committee. It intends to capture the influence of the Covid-19 pandemic on the increasing use of private and sensitive data, the ability to control such use and whether there is a need to take legal measures in order to improve such control.
Topics to be discussed will include:
-
The way health data has been used for prevention, diagnosis and care purposes in relation to Covid-19
-
The use of Covid-19 health data for subsequent research purposes
-
Health privacy in the labour context
-
Traceability apps
-
Cybersecurity
-
International transfers of data: means and purposes
Certificate of Attendance
Certificates of attendance for this webinar will be provided to all IBA members who have registered in advance and attended the live broadcast for a minimum of 30 minutes based on verified sign-in and sign-out times. Certificates can only be issued to the name provided at the time of registration.
Currently only IBA members will be provided with a certificate free of charge. IBA members should use the email address you have on file with the IBA to register for this webinar if you require a certificate of attendance.
Certificates for non-members are chargeable, please make enquiries at webinars@int-bar.org.
Cécile Théard-Jallu
De Gaulle Fleurance & Associés, Paris; Newsletter Officer, IBA Healthcare and Life Sciences Law Committee
Read biography
Jonás Bergstein
Bergstein Abogados, Montevideo; Vice Chair, IBA Healthcare and Life Sciences Law Committee
Read biography